Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability.


Journal

Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222

Informations de publication

Date de publication:
11 05 2020
Historique:
received: 06 08 2019
accepted: 10 03 2020
entrez: 13 5 2020
pubmed: 13 5 2020
medline: 29 5 2021
Statut: epublish

Résumé

Reduction or differences in facial expression are a core diagnostic feature of autism spectrum disorder (ASD), yet evidence regarding the extent of this discrepancy is limited and inconsistent. Use of automated facial expression detection technology enables accurate and efficient tracking of facial expressions that has potential to identify individual response differences. Children and adults with ASD (N = 124) and typically developing (TD, N = 41) were shown short clips of "funny videos." Using automated facial analysis software, we investigated differences between ASD and TD groups and within the ASD group in evidence of facial action unit (AU) activation related to the expression of positive facial expression, in particular, a smile. Individuals with ASD on average showed less evidence of facial AUs (AU12, AU6) relating to positive facial expression, compared to the TD group (p < .05, r = - 0.17). Using Gaussian mixture model for clustering, we identified two distinct distributions within the ASD group, which were then compared to the TD group. One subgroup (n = 35), termed "over-responsive," expressed more intense positive facial expressions in response to the videos than the TD group (p < .001, r = 0.31). The second subgroup (n = 89), ("under-responsive"), displayed fewer, less intense positive facial expressions in response to videos than the TD group (p < .001; r = - 0.36). The over-responsive subgroup differed from the under-responsive subgroup in age and caregiver-reported impulsivity (p < .05, r = 0.21). Reduced expression in the under-responsive, but not the over-responsive group, was related to caregiver-reported social withdrawal (p < .01, r = - 0.3). This exploratory study does not account for multiple comparisons, and future work will have to ascertain the strength and reproducibility of all results. Reduced displays of positive facial expressions do not mean individuals with ASD do not experience positive emotions. Individuals with ASD differed from the TD group in their facial expressions of positive emotion in response to "funny videos." Identification of subgroups based on response may help in parsing heterogeneity in ASD and enable targeting of treatment based on subtypes. ClinicalTrials.gov, NCT02299700. Registration date: November 24, 2014.

Sections du résumé

BACKGROUND
Reduction or differences in facial expression are a core diagnostic feature of autism spectrum disorder (ASD), yet evidence regarding the extent of this discrepancy is limited and inconsistent. Use of automated facial expression detection technology enables accurate and efficient tracking of facial expressions that has potential to identify individual response differences.
METHODS
Children and adults with ASD (N = 124) and typically developing (TD, N = 41) were shown short clips of "funny videos." Using automated facial analysis software, we investigated differences between ASD and TD groups and within the ASD group in evidence of facial action unit (AU) activation related to the expression of positive facial expression, in particular, a smile.
RESULTS
Individuals with ASD on average showed less evidence of facial AUs (AU12, AU6) relating to positive facial expression, compared to the TD group (p < .05, r = - 0.17). Using Gaussian mixture model for clustering, we identified two distinct distributions within the ASD group, which were then compared to the TD group. One subgroup (n = 35), termed "over-responsive," expressed more intense positive facial expressions in response to the videos than the TD group (p < .001, r = 0.31). The second subgroup (n = 89), ("under-responsive"), displayed fewer, less intense positive facial expressions in response to videos than the TD group (p < .001; r = - 0.36). The over-responsive subgroup differed from the under-responsive subgroup in age and caregiver-reported impulsivity (p < .05, r = 0.21). Reduced expression in the under-responsive, but not the over-responsive group, was related to caregiver-reported social withdrawal (p < .01, r = - 0.3).
LIMITATIONS
This exploratory study does not account for multiple comparisons, and future work will have to ascertain the strength and reproducibility of all results. Reduced displays of positive facial expressions do not mean individuals with ASD do not experience positive emotions.
CONCLUSIONS
Individuals with ASD differed from the TD group in their facial expressions of positive emotion in response to "funny videos." Identification of subgroups based on response may help in parsing heterogeneity in ASD and enable targeting of treatment based on subtypes.
TRIAL REGISTRATION
ClinicalTrials.gov, NCT02299700. Registration date: November 24, 2014.

Identifiants

pubmed: 32393350
doi: 10.1186/s13229-020-00327-4
pii: 10.1186/s13229-020-00327-4
pmc: PMC7212683
doi:

Banques de données

ClinicalTrials.gov
['NCT02299700']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Références

NPJ Digit Med. 2018 Jun 1;1:20
pubmed: 31304303
Front Neurosci. 2017 Sep 26;11:517
pubmed: 29018317
Soc Cogn Affect Neurosci. 2014 Sep;9(9):1435-42
pubmed: 23946000
J Autism Dev Disord. 2016 Jan;46(1):342-351
pubmed: 26267330
Brain. 2010 May;133(Pt 5):1515-25
pubmed: 20371509
Soc Cogn Affect Neurosci. 2015 Dec;10(12):1738-48
pubmed: 25999363
J Child Adolesc Psychopharmacol. 2017 Nov;27(9):814-822
pubmed: 28498053
J Autism Dev Disord. 2015 Nov;45(11):3409-23
pubmed: 25618212
J Autism Dev Disord. 2014 Jul;44(7):1766-72
pubmed: 24362795
Dev Sci. 2006 May;9(3):295-302
pubmed: 16669800
J Autism Dev Disord. 2019 Mar 19;:
pubmed: 30888551
Mol Autism. 2016 Nov 11;7:46
pubmed: 27895883
Res Autism Spectr Disord. 2012 Jul;6(3):1150-1155
pubmed: 22773928
J Am Acad Child Adolesc Psychiatry. 2013 Jul;52(7):679-88
pubmed: 23800481
Autism. 2014 Aug;18(6):704-11
pubmed: 24121180
J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1324-1332
pubmed: 17885574
Neurosci Biobehav Rev. 2016 May;64:252-71
pubmed: 26915928
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Clin Psychol Rev. 2010 Mar;30(2):217-37
pubmed: 20015584
J Paediatr Child Health. 2018 Oct;54(10):1068-1072
pubmed: 30294997
J Autism Dev Disord. 2015 Jan;45(1):75-89
pubmed: 25037584
J Autism Dev Disord. 2019 Jan;49(1):279-293
pubmed: 30298462
Front Neurosci. 2019 Feb 27;13:111
pubmed: 30872988
J Abnorm Child Psychol. 2018 Jul;46(5):1111-1120
pubmed: 28993938
CNS Spectr. 2004 Jan;9(1):36-47
pubmed: 14999174
J Autism Dev Disord. 2003 Aug;33(4):427-33
pubmed: 12959421
Autism Res. 2018 Dec;11(12):1586-1601
pubmed: 30393953
Psychol Sci. 2013 May;24(5):723-32
pubmed: 23528789
Behav Res Methods. 2010 Nov;42(4):1079-86
pubmed: 21139175
J Autism Dev Disord. 2015 Nov;45(11):3405-8
pubmed: 26391886
J Pers Soc Psychol. 1993 Jan;64(1):83-93
pubmed: 8421253

Auteurs

Abigail Bangerter (A)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA. abangert@its.jnj.com.

Meenakshi Chatterjee (M)

Digital Phenotyping Group, Discovery Sciences, Janssen Research & Development, Spring House, PA, USA.

Joseph Manfredonia (J)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA.

Nikolay V Manyakov (NV)

Digital Phenotyping Group, Discovery Sciences, Janssen Research & Development, Beerse, Belgium.

Seth Ness (S)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA.

Matthew A Boice (MA)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA.

Andrew Skalkin (A)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA.

Matthew S Goodwin (MS)

Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.

Geraldine Dawson (G)

Department of Psychiatry and Behavioral Sciences, Duke Center for Autism and Brain Development, Duke Institute for Brain Sciences, Duke University, Durham, NC, USA.

Robert Hendren (R)

Department of Psychiatry, School of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Bennett Leventhal (B)

Department of Psychiatry, School of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Frederick Shic (F)

Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, WA, USA.
Department of Pediatrics, University of Washington, Seattle, WA, USA.

Gahan Pandina (G)

Neuroscience Therapeutic Area, Janssen Research & Development, Titusville, NJ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH